Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07336537 · ClinicalTrials.gov registry record · NA

Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software

A NA study of Chronic Pain and Mental Health Disorders, sponsored by AugMend Health.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT07336537 is a NA study of Chronic Pain and Mental Health Disorders that is actively recruiting participants, run by AugMend Health. The registered enrollment target is 100 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07336537, a NA study of Chronic Pain and Mental Health Disorders, is actively recruiting participants, sponsored by AugMend Health.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

This research study is being conducted to evaluate digital software tools that collect health information through conversations. The study will test how acceptable, feasible, and usable these conversational software programs are for patients with chronic pain. Purpose of the Study: The goal is to understand whether digital conversational tools can effectively gather biopsychosocial information (biological, psychological, and social factors related to health) from patients experiencing chronic pain. Biopsychosocial information includes details about your physical symptoms, emotional well-being, social circumstances, and how these factors interact to affect your health. These digital tools are designed to have conversation-like interactions with patients to collect this comprehensive health data in a more natural and engaging way. What Participation Involves: If you join this study, you will interact with digital conversational software that will ask you questions about your health, pain experience, and related factors. The software is designed to communicate with you in a conversational manner, similar to talking with a healthcare provider, to gather information about your condition. You will be asked about various aspects of your chronic pain experience, including how it affects your daily life, your emotional state, and your social interactions. Who Can Participate: This study is looking for participants who have chronic pain conditions. Medical providers who treat patients with chronic pain are encouraged to refer eligible patients to this study. Healthcare providers interested in referring patients or learning more about the study can contact the study sponsor, AugMend Health Inc. Why This Research Matters: Chronic pain affects millions of people and understanding the full scope of how it impacts patients requires collecting detailed information about physical, psychological, and social factors. Traditional methods of collecting this information can be ti

Interventions

  • OTHER Digital Biopsychosocial Conversational Data Collection Software
  • OTHER Standard Digital Questionnaire Data Collection

Study Locations (1)

Massachusetts

  • AugMend Health at MIT.nano Immersion Lab - Cambridge

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2025-10-03
Est. Completion 2026-07-31
Phase NA

Sponsor

AugMend Health

1 total trials

What the Registry Record Tells You About NCT07336537

The ClinicalTrials.gov registry entry for NCT07336537 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (87% lower). The listed sponsor is AugMend Health, which has 1 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Chronic Pain appearing as the primary indexed condition, and to 2 interventions - of which Digital Biopsychosocial Conversational Data Collection Software is the first listed.

NCT07336537 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT07336537 about?

NCT07336537 is a clinical study titled "Evaluating the Acceptability, Feasibility and Usability of Various Conversational Data Collection Software". This research study is being conducted to evaluate digital software tools that collect health information through conversations. The study will test how acceptable, feasible, and usable these conversational software programs are for patients with chronic pain. Purpose of the Study: The goal is to ...

What is the current status of trial NCT07336537?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-10-03. Estimated completion is 2026-07-31.

What conditions does trial NCT07336537 study?

This clinical trial studies the following conditions: Chronic Pain, Mental Health Disorders, Behavioral Health Challenges, Ecological Momentary Assessment Best Practices.

What interventions are being tested in trial NCT07336537?

The interventions under investigation include: Digital Biopsychosocial Conversational Data Collection Software (OTHER), Standard Digital Questionnaire Data Collection (OTHER).

Who is sponsoring clinical trial NCT07336537?

This trial is sponsored by AugMend Health, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07336537 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.